Literature DB >> 15673740

Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain.

Masayuki Saijo1, Tatsuo Suzutani, Shigeru Morikawa, Ichiro Kurane.   

Abstract

Foscarnet is widely used for the treatment of acyclovir-resistant herpesvirus infections, and foscarnet-resistant herpesvirus infections are a serious concern in immunocompromised patients. Twenty-seven single-plaque isolates of herpes simplex virus type 1 (HSV-1) resistant to foscarnet were selected from foscarnet- and acyclovir-sensitive HSV-1 strain TAS by exposure to foscarnet, and the DNA polymerase genes were analyzed. The sensitivities of these mutants to foscarnet, cidofovir, S2242, acyclovir, ganciclovir, and penciclovir were determined. A single amino acid substitution, double amino acid substitutions, and a combination of a single amino acid substitution with a deletion or insertion of amino acid residues in the viral DNA polymerase were demonstrated in 21, 4, and 2 isolates, respectively. Of the 27 isolates, an amino acid substitution of serine for asparagine at amino acid position 724 in the DNA polymerase (724 S-N) was detected in 8 isolates. An amino acid substitution in conserved region II was demonstrated in these eight isolates as well as four other isolates. The mutation in the DNA polymerase responsible for resistance to foscarnet was located between the pre-IV region and conserved region V, especially within conserved region II. All the isolates were sensitive or hypersensitive to cidofovir and ganciclovir. Seven, 5, and 15 of the 27 isolates were also sensitive to S2242, acyclovir, and penciclovir, respectively. Thus, most of the foscarnet-resistant HSV-1 isolates were sensitive or hypersensitive to cidofovir and ganciclovir.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15673740      PMCID: PMC547286          DOI: 10.1128/AAC.49.2.606-611.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation.

Authors:  Amelia A Langston; Istvan Redei; Angela M Caliendo; Jyoti Somani; Don Hutcherson; Sagar Lonial; Silvana Bucur; Judy Cherry; Andrew Allen; Edmund K Waller
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

2.  Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.

Authors:  Masayuki Saijo; Tatsuo Suzutani; Erik De Clercq; Masahiro Niikura; Akihiko Maeda; Shigeru Morikawa; Ichiro Kurane
Journal:  Antiviral Res       Date:  2002-12       Impact factor: 5.970

3.  Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.

Authors:  Tatsuo Suzutani; Ken Ishioka; Erik De Clercq; Kei Ishibashi; Hisatoshi Kaneko; Toshihiko Kira; Koh-Ichi Hashimoto; Masahiro Ogasawara; Katsuki Ohtani; Nobutaka Wakamiya; Masayuki Saijo
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

4.  Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.

Authors:  Y Chen; C Scieux; V Garrait; G Socié; V Rocha; J M Molina; D Thouvenot; F Morfin; L Hocqueloux; L Garderet; H Espérou; F Sélimi; A Devergie; G Leleu; M Aymard; F Morinet; E Gluckman; P Ribaud
Journal:  Clin Infect Dis       Date:  2000-10-10       Impact factor: 9.079

5.  Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant.

Authors:  N Blot; P Schneider; P Young; C Janvresse; D Dehesdin; P Tron; J P Vannier
Journal:  Bone Marrow Transplant       Date:  2000-10       Impact factor: 5.483

6.  Successful treatment of an aciclovir-resistant herpes simplex type 2 infection with cidofovir in an AIDS patient.

Authors:  T Kopp; A Geusau; A Rieger; G Stingl
Journal:  Br J Dermatol       Date:  2002-07       Impact factor: 9.302

Review 7.  Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms.

Authors:  Christian Gilbert; Julie Bestman-Smith; Guy Boivin
Journal:  Drug Resist Updat       Date:  2002-04       Impact factor: 18.500

8.  Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.

Authors:  Doris Chibo; Anne Mijch; Richard Doherty; Christopher Birch
Journal:  J Clin Virol       Date:  2002-08       Impact factor: 3.168

9.  Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids.

Authors:  Julie Bestman-Smith; Guy Boivin
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.

Authors:  Masayuki Saijo; Yukiharu Yasuda; Hiromasa Yabe; Shunichi Kato; Tatsuo Suzutani; Erik De Clercq; Masahiro Niikura; Akihiko Maeda; Ichiro Kurane; Shigeru Morikawa
Journal:  J Med Virol       Date:  2002-09       Impact factor: 2.327

View more
  5 in total

Review 1.  Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Complex management of resistant oral herpes simplex virus infection following hematopoietic stem cell transplantation: potential role of topical cidofovir.

Authors:  Joel B Epstein; Sara Gharapetian; Ali R Rejali; Rachel Zabner; Michael Lill; Dimitrios Tzachanis
Journal:  Support Care Cancer       Date:  2016-05-10       Impact factor: 3.603

3.  Novel Method Based on Real-Time Cell Analysis for Drug Susceptibility Testing of Herpes Simplex Virus and Human Cytomegalovirus.

Authors:  Jocelyne Piret; Nathalie Goyette; Guy Boivin
Journal:  J Clin Microbiol       Date:  2016-06-01       Impact factor: 5.948

4.  Anti-Viral Evaluation of Sesquiterpene Coumarins from Ferula assa-foetida against HSV-1.

Authors:  Alireza Ghannadi; Khadijeh Fattahian; Yalda Shokoohinia; Mandana Behbahani; Alireza Shahnoush
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

5.  Study of Antiherpetic Efficiency of Phosphite of Acycloguanosine Ableto Over come the Barrier of Resistance to Acyclovir.

Authors:  V L Andronova; M V Jasko; M K Kukhanova; G A Galegov; Yr S Skoblov; S N Kochetkov
Journal:  Acta Naturae       Date:  2016 Jan-Mar       Impact factor: 1.845

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.